Dyadic International Inc. (DYAI)

$0.53

up-down-arrow $0.01 (1.25%)

As on 08-Sep-2026 12:16EDT

Market cap

info icon

$21 Mln

Revenue (TTM)

info icon

$3 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

21

Div. Yield

info icon

0 %

Dyadic International (DYAI) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.53 High: 0.58

52 Week Range

Low: 0.48 High: 1.60

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -28.3 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -2.9

  • Debt to EquityDebt to Equity information

    -2.1

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.2

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    40,063,703

10 Years Aggregate

CFO

$-58.50 Mln

EBITDA

$-89.38 Mln

Net Profit

$1.65 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Dyadic International (DYAI)
-44.0 -47.4 -25.8 -42.1 -34.0 -38.5 -9.5
BSE Sensex
-10.7 -3.7 1.8 -6.4 4.5 5.3 10.1
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 08-Sep-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Dyadic International (DYAI)
-46.3 8.6 30.9 -72.8 -16.0 3.9 174.1
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Dyadic International (DYAI)
0.5 20.8 3.5 -7.6 -41.8 -- -- 21.0
86.1 12,161.6 669.5 -320.0 -0.8 -71.1 -- 26.2
268.7 17,746.8 1,054.4 755.9 5.7 -- 20.9 10.5
75.4 10,109.8 71.0 -894.0 -1,175.8 -- -- 60.5
59.2 14,621.6 2,435.9 860.6 31.0 43 18.6 7.9
107.8 12,506.3 1,663.7 413.6 36.3 430 32.3 86.7
352.2 10,603.5 440.5 241.5 33.4 18.7 44.9 8.1
119.0 9,761.1 105.0 -299.7 -227.2 -19.4 -- 6.5
531.9 12,501.2 1,283.9 -325.1 -19.0 -57.7 -- 23.9
590.9 16,503.9 2,782.3 491.5 21.1 110.1 34.7 38.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Dyadic International (DYAI)

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary...  expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. 

  • Founder, CEO, President & Director

    Mr. Mark A. Emalfarb

  • Founder, CEO, President & Director

    Mr. Mark A. Emalfarb

  • Headquarters

    Jupiter, FL

  • Website

    https://www.dyadic.com

FAQs for Dyadic International (DYAI)

The share price of Dyadic International Inc (DYAI) is $0.53 (NASDAQ) as of 08-Sep-2026 12:16 EDT. Dyadic International Inc (DYAI) has given a return of -33.98% in the last 3 years.

Since, TTM earnings of Dyadic International Inc (DYAI) is negative, P/E ratio is not available.
The P/B ratio of Dyadic International Inc (DYAI) is 21.01 times as on 04-Sep-2026, a 294 premium to its peers’ median range of 5.33 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-4.16
24.88
2024
-8.83
20.77
2023
-6.83
7.89
2022
-3.61
3.17
2021
-9.71
6.90

The 52-week high and low of Dyadic International Inc (DYAI) are Rs 1.60 and Rs 0.48 as of 08-Sep-2026.

Dyadic International Inc (DYAI) has a market capitalisation of $ 21 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Dyadic International Inc (DYAI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...